Work

Prognostic Value of the Pretreatment Global Immune–Nutrition–Inflammation Index in Nasopharyngeal Carcinoma: A Multicenter Retrospective Cohort Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background and Objectives: Nasopharyngeal carcinoma (NPC) exhibits substantial biological heterogeneity that is not fully captured by TNM staging. We investigated the prognostic significance of the pretreatment Global Immune–Nutrition–Inflammation Index (GINI) in NPC. Materials and Methods: This multicenter retrospective cohort study included 96 patients with pathologically confirmed NPC who were treated between 2015 and 2024. GINI was calculated using neutrophil, lymphocyte, monocyte, and platelet counts, along with serum C-reactive protein and albumin levels. The optimal cutoff was identified by receiver operating characteristic analysis. Survival outcomes were assessed with Kaplan–Meier and multivariable Cox regression analyses. Results: The optimal GINI cutoff was 3403 (AUC: 0.726, p < 0.001), which showed a numerically higher AUC than the neutrophil-to-lymphocyte ratio (NLR; AUC: 0.674, p = 0.003). High GINI was associated with advanced stage (p = 0.008), shorter overall survival (OS) (23 vs. 95 months, p < 0.001), and shorter disease-free survival (DFS) (16 vs. 95 months, p < 0.001). In multivariable analysis, high GINI remained significantly associated with poorer OS and DFS. Conclusions: Pretreatment GINI was strongly associated with survival in patients with NPC and may serve as a useful adjunctive prognostic marker. Further prospective studies and external validation are required before its incorporation into clinical risk-stratification strategies.
Source: Medicina
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7235711500
FWCI:
Cites: 27
Cited by:
Related to: 10